Pharmacokinetic study of mycophenolic acid in Iranian kidney transplant patients.

Background: The purpose of this study was to characterize the pharmacokinetic parameters of mycophenolic acid (MPA) in Iranian kidney transplant patients. Methods: Plasma MPA concentration of mycophenolate mofetile (MMF) 1 gram two times a day was measured in 21 Iranian kidney transplant recipients...

Full description

Bibliographic Details
Main Authors: Kheirollah Gholami, Mohammadreza Rouini, Niayesh Mohebbi, Iman Karimzadeh, Mehdi Ahadi-barzoki, Mahboob Lessan-pezeshki, Saeed Rezaee
Format: Article
Language:English
Published: Research Center for Rational Use of Drugs (RCRUD) 2015-10-01
Series:Journal of Pharmaceutical Care
Subjects:
Online Access:https://jpc.tums.ac.ir/index.php/jpc/article/view/4
_version_ 1811265439579242496
author Kheirollah Gholami
Mohammadreza Rouini
Niayesh Mohebbi
Iman Karimzadeh
Mehdi Ahadi-barzoki
Mahboob Lessan-pezeshki
Saeed Rezaee
author_facet Kheirollah Gholami
Mohammadreza Rouini
Niayesh Mohebbi
Iman Karimzadeh
Mehdi Ahadi-barzoki
Mahboob Lessan-pezeshki
Saeed Rezaee
author_sort Kheirollah Gholami
collection DOAJ
description Background: The purpose of this study was to characterize the pharmacokinetic parameters of mycophenolic acid (MPA) in Iranian kidney transplant patients. Methods: Plasma MPA concentration of mycophenolate mofetile (MMF) 1 gram two times a day was measured in 21 Iranian kidney transplant recipients receiving treatment. Patients who entered the study had been transplanted for more than 3 months and their drug level was supposed to be at steady state. MMF concentration was measured with High- Performance Liquid Chromatography (HPLC). Results: The plasma MPA concentration-time curve was characterized by an early sharp peak at about 1 hour postdose. The mean Area Under Curve (AUC), Cmax and Tmax were 47.0±18.3 µg.h/ml, 18.6±8.5 µg/ml and 1.0±0.5 hours respectively. Conclusion: The plasma MPA concentration-time curve pattern of Iranian patients was similar and consistent with previously reported profiles in other populations taking the same dose.
first_indexed 2024-04-12T20:24:09Z
format Article
id doaj.art-7bf10d59cd5d43ce8c433d41261879ce
institution Directory Open Access Journal
issn 2322-4630
2322-4509
language English
last_indexed 2024-04-12T20:24:09Z
publishDate 2015-10-01
publisher Research Center for Rational Use of Drugs (RCRUD)
record_format Article
series Journal of Pharmaceutical Care
spelling doaj.art-7bf10d59cd5d43ce8c433d41261879ce2022-12-22T03:17:55ZengResearch Center for Rational Use of Drugs (RCRUD)Journal of Pharmaceutical Care2322-46302322-45092015-10-0111Pharmacokinetic study of mycophenolic acid in Iranian kidney transplant patients.Kheirollah Gholami0Mohammadreza Rouini1Niayesh Mohebbi2Iman Karimzadeh3Mehdi Ahadi-barzoki4Mahboob Lessan-pezeshki5Saeed Rezaee6Clinical Pharmacy Department, Faculty of Pharmacy and Research Center for Rational Use of Drugs, Tehran University of Medical Sciences, Tehran, IranDepartment of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, IranClinical Pharmacy Department, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, IranClinical Pharmacy Department, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, IranFood and Drug Administration, Ministry of Health, Tehran, IranDepartment of Internal Medicine, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, IranDepartment of Pharmaceutics, Faculty of Pharmacy, Ahvaz University of Medical Sciences, Ahvaz, IranBackground: The purpose of this study was to characterize the pharmacokinetic parameters of mycophenolic acid (MPA) in Iranian kidney transplant patients. Methods: Plasma MPA concentration of mycophenolate mofetile (MMF) 1 gram two times a day was measured in 21 Iranian kidney transplant recipients receiving treatment. Patients who entered the study had been transplanted for more than 3 months and their drug level was supposed to be at steady state. MMF concentration was measured with High- Performance Liquid Chromatography (HPLC). Results: The plasma MPA concentration-time curve was characterized by an early sharp peak at about 1 hour postdose. The mean Area Under Curve (AUC), Cmax and Tmax were 47.0±18.3 µg.h/ml, 18.6±8.5 µg/ml and 1.0±0.5 hours respectively. Conclusion: The plasma MPA concentration-time curve pattern of Iranian patients was similar and consistent with previously reported profiles in other populations taking the same dose.https://jpc.tums.ac.ir/index.php/jpc/article/view/4Mycophenolate mofetilMycophenolic acidPharmacokineticsArea Under CurveKidney transplantation
spellingShingle Kheirollah Gholami
Mohammadreza Rouini
Niayesh Mohebbi
Iman Karimzadeh
Mehdi Ahadi-barzoki
Mahboob Lessan-pezeshki
Saeed Rezaee
Pharmacokinetic study of mycophenolic acid in Iranian kidney transplant patients.
Journal of Pharmaceutical Care
Mycophenolate mofetil
Mycophenolic acid
Pharmacokinetics
Area Under Curve
Kidney transplantation
title Pharmacokinetic study of mycophenolic acid in Iranian kidney transplant patients.
title_full Pharmacokinetic study of mycophenolic acid in Iranian kidney transplant patients.
title_fullStr Pharmacokinetic study of mycophenolic acid in Iranian kidney transplant patients.
title_full_unstemmed Pharmacokinetic study of mycophenolic acid in Iranian kidney transplant patients.
title_short Pharmacokinetic study of mycophenolic acid in Iranian kidney transplant patients.
title_sort pharmacokinetic study of mycophenolic acid in iranian kidney transplant patients
topic Mycophenolate mofetil
Mycophenolic acid
Pharmacokinetics
Area Under Curve
Kidney transplantation
url https://jpc.tums.ac.ir/index.php/jpc/article/view/4
work_keys_str_mv AT kheirollahgholami pharmacokineticstudyofmycophenolicacidiniraniankidneytransplantpatients
AT mohammadrezarouini pharmacokineticstudyofmycophenolicacidiniraniankidneytransplantpatients
AT niayeshmohebbi pharmacokineticstudyofmycophenolicacidiniraniankidneytransplantpatients
AT imankarimzadeh pharmacokineticstudyofmycophenolicacidiniraniankidneytransplantpatients
AT mehdiahadibarzoki pharmacokineticstudyofmycophenolicacidiniraniankidneytransplantpatients
AT mahbooblessanpezeshki pharmacokineticstudyofmycophenolicacidiniraniankidneytransplantpatients
AT saeedrezaee pharmacokineticstudyofmycophenolicacidiniraniankidneytransplantpatients